PAPER Cui C, Chen J, Shen H, Zhang B

Derivation of induced pluripotent stem cell TUSMi013-A from a 66-year-old Chinese Han Parkinson's disease patient carrying VPS13C and TBP mutations.

Stem Cell Res. 2024 Dec 18;83:103631. Epub 2024 Dec 18 PubMed.

PAPER Chemparathy A, Le Guen Y, Zeng Y, Gorzynski J, Jensen TD, Yang C, Kasireddy N, Talozzi L, Belloy M, Stewart I, Gitler AD, Wagner AD, Mormino E, Henderson VW, Wyss-Coray T, Ashley E, Cruchaga C, Greicius MD

A 3'UTR Insertion Is a Candidate Causal Variant at the TMEM106B Locus Associated With Increased Risk for FTLD-TDP.

Neurol Genet. 2024 Feb;10(1):e200124. Epub 2024 Feb 5 PubMed.

PAPER Borbolis F, Ploumi C, Palikaras K

Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseases.

NPJ Metab Health Dis. 2025;3(1):4. Epub 2025 Feb 3 PubMed.

PAPER Chen X, Tian Q, Gao M, Zhou X, Zhou C

Lingguizhugan decoction enhances autophagy of Alzheimer's disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro.

Front Aging Neurosci. 2025;17:1478199. Epub 2025 Jan 22 PubMed.

PAPER Antonioni A, Raho EM, Granieri E, Koch G

Frontotemporal dementia. How to deal with its diagnostic complexity?

Expert Rev Neurother. 2025 Feb 7;:1-35. Epub 2025 Feb 7 PubMed.

PAPER Zamani A, Walker AK, Wright DK

Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice.

Neurobiol Dis. 2025 Feb 4;206:106832. Epub 2025 Feb 4 PubMed.

PAPER Park S, Park M, Kim EJ, Kim JJ, Cho J, Huh Y

Distinct disruptions in CA1 and CA3 place cell function in Alzheimer's disease mice.

iScience. 2025 Feb 21;28(2):111631. Epub 2025 Jan 10 PubMed.

PAPER Schwarze-Taufiq TA, Pranoto IK, Hui K, Kinoshita C, Yu O, Crane PK, Gray SL, Young JE

Anticholinergic drugs and dementia risk: Using stem cell-based studies to complement pharmacoepidemiology.

Alzheimers Dement (N Y). 2025;11(1):e70040. Epub 2025 Feb 5 PubMed.

Paul Coleman

Arizona State University
United States

Julio Rojas

Memory and Aging Center, Weill Insititute for Neurosciences, University of California, San Francisco
United States

PAPER Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Grone B, Zilberter M, Yip O, Rao A, Nelson MR, Hao Y, Thomas R, Yoon SY, Arriola P, Huang Y

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits.

Nat Aging. 2023 Mar;3(3):275-296. Epub 2023 Feb 20 PubMed.

PAPER Babu AT, Abdul Vahid A, Reselammal DS, Kizhakkeduth ST, Pinhero F, Vijayan V

Exploring the Potential Interaction between the Functional Prion Protein CPEB3 and the Amyloidogenic Pathogenic Protein Tau.

J Phys Chem B. 2025 Feb 5; Epub 2025 Feb 5 PubMed.

PAPER Lee BH, Cevizci M, Lieblich SE, Galea LA

Sex-specific influences of APOEε4 genotype on hippocampal neurogenesis and progenitor cells in middle-aged rats.

Biol Sex Differ. 2025 Feb 5;16(1):10. PubMed.

PAPER Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Paul J, Tolar M

Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease.

Clin Pharmacokinet. 2025 Feb 5; Epub 2025 Feb 5 PubMed.

PAPER Zhu H, Huang C, Luo Z, Wu L, Cheng X, Wu H

Porphyromonas gingivalis Induces Disturbance of Kynurenine Metabolism Through the Gut-Brain Axis: Implications for Alzheimer's Disease.

J Dent Res. 2025 Feb 4;:220345241303141. Epub 2025 Feb 4 PubMed.